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Abstract
Objectives—To improve clinical practice and increase postpartum visit Type 2 diabetes mellitus 
(T2DM) screening rates in women with a history of gestational diabetes mellitus (GDM).
Methods—We recruited clinical sites with at least half of pregnant patients enrolled in Medicaid 
to participate in an 18-month quality improvement (QI) project. To support clinical practice 
changes, we developed provider and patient toolkits with educational and clinical practice 
resources. Clinical subject-matter experts facilitated a learning network to train sites and promote 
discussion and learning among sites. Sites submitted data from patient chart reviews monthly for 
key measures that we used to provide rapid-cycle feedback. Providers were surveyed at 
completion regarding toolkit usefulness and satisfaction.
Results—Of fifteen practices recruited, twelve remained actively engaged. We disseminated 
more than 70 provider and 2345 patient toolkits. Documented delivery of patient education 
improved for timely GDM prenatal screening, reduction of future T2DM risk, smoking cessation, 
and family planning. Sites reported toolkits were useful and easy to use. Of women for whom 
postpartum data were available, 67 % had a documented postpartum visit and 33 % had a 
postpartum T2DM screen. Lack of information sharing between prenatal and postpartum care 
providers was are barriers to provision and documentation of care.
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Conclusions for Practice—QI and toolkit resources may improve the quality of prenatal 
education. However, postpartum care did not reach optimal levels. Future work should focus on 
strategies to support coordination of care between obstetrical and primary care providers.
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Purpose
In the United States, approximately 28 million persons have diabetes—triple the number 
from 3 decades ago—of whom 13.4 million are women (CDC 2014). An estimated 30 % of 
these women previously had gestational diabetes mellitus (GDM) (Cheung 2003), which is 
characterized by abnormal carbohydrate metabolism first identified in pregnancy (ACOG 
2013). GDM affects up to 9.2 % of pregnancies (DeSisto 2015) with increasing prevalence 
(Bardenheier 2015). While GDM typically resolves after pregnancy, women with a history 
of GDM remain at high risk for developing type 2 diabetes mellitus (T2DM). The highest 
risk period for T2DM incidence among these women is immediately postpartum (Feig 
2008), with incidence estimated to be 3–24 % in the first year postpartum and up to 50 % in 
the first 5 years (Bellamy 2009). Overall, between 50 and 70 % of women with GDM 
develop T2DM at some point in life (ACOG 2013), making lifelong monitoring critical to 
adequately capturing the risk of diabetes.
Both the American Diabetes Association (ADA) (ADA 2013) and American College of 
Obstetricians and Gynecologists (ACOG) (ACOG 2013) guidelines recommend that women 
with a history of GDM have a postpartum visit and be screened for persistent hyperglycemia 
and/or T2DM 6–12 weeks after delivery and subsequently, every 1–3 years. Lifelong 
screening enables ongoing prevention messaging, timely diagnosis of pre-diabetes and 
T2DM, and referral for early treatment. T2DM development in women with GDM history 
can prevented or delayed by lifestyle modifications and breastfeeding (Ratner 2008; 
Gunderson 2015). Despite this, reported postpartum screening rates are sub-optimal, ranging 
from 20 to 60 % (Yarrington 2015). Screening is lower among women who are low income 
and who have more severe GDM (Hunt 2008). Providers often lack knowledge of the extent 
of T2DM risk in women with GDM history (Rodgers 2014; Ko 2013a), and both women 
with GDM history and providers admit to not having adequate patient education materials 
and community resources to reduce risk (Rodgers 2014; Ko 2013a, b; Weber 2015). 
However, both prenatal and primary care providers (PCP) have expressed a desire for 
patient-centered materials and local community resources (Oza-Frank 2014).
The Ohio Gestational Diabetes Postpartum Care Learning Collaborative (referred to as the 
Collaborative in the remainder of this paper) was formed in January 2014 as a quality 
improvement initiative. The primary objectives of the intervention were to increase 
postpartum visit rates and postpartum T2DM screening rates among women following a 
GDM pregnancy. Secondary objectives were to educate women with GDM on T2DM risk 
and risk reduction methods. To support these objectives, toolkits were developed and tested. 
Patient toolkits were designed to increase the delivery of and expand the content of prenatal 
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education. Provider toolkits were designed to improve clinical care and office work flow for 
timely GDM and postpartum T2DM screening. This paper describes the intervention and the 
observed impact on quality improvement indicators of care provision.
Description
The Social and Behavioral Sciences Institutional Review Board (IRB) at the Ohio State 
University determined this initiative to be a quality improvement activity that did not require 
IRB review. The work was conducted in accord with prevailing ethical principles.
The Collaborative consisted of clinical and public health subject matter experts, state health 
department leadership in both chronic disease and maternal and child health, quality 
improvement experts, and pilot site teams. To ensure consensus about root causes and 
effective strategies, all members of the Collaborative participated in development of a key 
driver diagram for the quality improvement project (Fig. 1). Key drivers included 
standardization of clinical guidelines in GDM management; increased access to maternal 
health services; coordination of care; and promotion of a culture of safety and improvement. 
A key driver of particular focus in this pilot was the increased awareness of risks and 
benefits of optimal management of GDM and risk reduction for T2DM among pregnant 
women, nurses, diabetes educators, office staff and obstetric care providers, both physicians 
and midwives.
Pilot Sites
We recruited clinical sites (N = 15) with at least half of pregnant patients enrolled in 
Medicaid, as the population had higher rates and was of interest to the state. Twelve sites 
remained engaged throughout the project period. Recruitment aimed for representation 
across size of annual GDM patient population (small: <200; medium: 200–500; and large: 
>500) and geography (Fig. 2). Recruited sites were suggested by public health or clinical 
subject matter experts or were known to the quality improvement experts from participation 
in prior projects. Each site team included at least one physician, nurse, and administrative 
staff member. Some teams also included a diabetes educator. Team sizes ranged from three 
to seven individuals but did not correlate with site size. All participation was voluntary; no 
financial incentives were offered.
Project Components
This 18-month project utilized three components: (1) development of educational and 
clinical care toolkits for providers and patients (see online Appendix), (2) rapid cycle data 
feedback to promote engagement and monitor progress, and (3) monthly learning sessions, 
facilitated by clinical subject-matter experts, to provide training on specific topics, answer 
questions, and facilitate discussion among pilot sites. The first 6 months were spent in 
development of the patient and provider toolkits and site recruitment. The next 12 months 
were spent engaged in data collection, learning sessions and quality improvement work itself 
(Fig. 3).
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Toolkit Development and Evaluation
Provider and patient toolkits were developed to serve as resources to support clinical 
practice change and increase patient awareness of GDM. Toolkit development was informed 
by a literature review and state-specific data. State data sources included a data book with 
quantitative GDM-related data compiled from six sources (Oza-Frank 2011), quantitative 
data on provider knowledge and practices from a survey of obstetric and primary care 
providers (PCPs) (Oza-Frank 2014; Ko 2013a, b; Rodgers 2014) and qualitative data from 
focus groups with women with a history of GDM (Oza-Frank 2015; Weber 2015). Four 
frontline obstetrical providers, including maternal-fetal medicine physicians specializing in 
diabetes with pregnancy, a registered dietician/epidemiologist, and public health 
professionals contributed to the development of the provider toolkits. State public health 
experts compiled an inventory of state and local resources for T2DM risk reduction.
The provider toolkit was a three pocket folder with work sheets and tools for office flow and 
postpartum care, resources for GDM management, and general prenatal resources. The 
included patient care algorithms were adapted from ACOG (ACOG 2013). Two separate 
patient toolkits were singlering bound 5 × 7 inch booklets. One patient booklet was intended 
for pregnant women considered at high-risk of developing GDM as defined by the presence 
of one or more of these risk factors: prior history of GDM, known impaired glucose 
metabolism, polycystic ovarian syndrome, body mass index greater than or equal to 30, or 
prior child with a birth weight greater than ten pounds. The booklet contained general 
prenatal care information including a broad overview of GDM and maintenance of a healthy 
lifestyle. The second patient toolkit was directed toward pregnant women with a GDM 
diagnosis and contained resources specific to GDM education and management during 
pregnancy, prevention of T2DM, and postpartum care. Patient booklets were written at a 
fourth to fifth grade reading level and made available in English and Spanish.
Feedback on the clinical toolkit and consumer resources were solicited from practice sites 
quarterly throughout this pilot. At project completion sites were asked to complete a 20-
question toolkit survey (see online Appendix 2). The three sites with wireless capability 
administered a short questionnaire to a convenience sample of patients to determine patient 
satisfaction with their care and resources provided. Patients were asked if they had a 
diagnosis of GDM, whether they received the patient toolkit, and what they learned.
Quality Improvement Data Collection and Feedback Loops.
The Model of Improvement (Langley 2009) championed by the Institute for Healthcare 
Improvement guided this project. This model uses rapid Plan-Do-Study-Act cycles to test a 
change or group of changes in selected measures on a small scale in a brief period of time, 
such as days rather than months. Observed improvements in key measures guide whether the 
tested change is adopted within clinics and expanded beyond test sites. If the change is 
unsuccessful, it is abandoned and another possible change is tested. Aggregate data allow 
sites to monitor progress relative to peers and to established targets. Thus, rapid feedback of 
site-specific and aggregate data is a key principle of quality improvement methods.
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Quality improvement measures for this project are listed in Table 1. Sites performed 
monthly chart reviews to collect data on these measures. Each site was asked to review up to 
20 charts for women between 33 and 36 weeks gestation with a GDM diagnosis who was 
treated that month. Reviewing this number of charts took approximately 2–3 h, which was a 
manageable commitment for most sites. When possible, sites were encouraged to select 
women eligible for or enrolled in Medicaid, or women who were uninsured. Additionally, 
for any woman whose chart had been reviewed during her prenatal period, postpartum data 
were collected on the following measures: (a) delivery date, (b) attendance at postpartum 
visit (yes or no), (c) date of postpartum visit, and (d) receipt of oral glucose tolerance test.
Data on quality improvement measures were entered directly into a secure, web-based data 
portal, developed on the SAS 9.3 Enterprise Business Intelligence (EBI) platform. No 
identifiable private health information was entered. Monthly, aggregate trend data were 
shared through monthly learning sessions and site-specific data through coaching calls. Sites 
could also access customizable reports on the portal.
Monthly Learning Sessions and Individual Coaching
The Collaborative was anchored by monthly learning sessions. Within a 1-hour webinar 
format, sessions included a discussion of toolkit resources, best practices for treating women 
diagnosed with GDM and a review of aggregate data on key quality improvement measures 
to identify areas for improvement to accelerate change. Quality improvement experts held up 
to four optional individual coaching calls with each project team quarterly to provide site-
specific technical assistance. Calls focused on site-specific data and needs such as data entry 
and use of resources.
Results
Fifteen practices were recruited to participate; twelve remained actively engaged throughout 
the project period. Active engagement was defined as participating in the prework call, 
submitting at least 7 of 10 months of data collection, and participating in at least seven of ten 
technical assistance calls. For the three sites that discontinued participation, the primary 
reason was inability to commit time (3–5 h monthly) and resources. Nine of the sites 
participated in at least two of the four coaching calls, with seven participating in three or 
more calls.
More than seventy provider toolkits and 2345 patient toolkits (845 prenatal and 1500 GDM) 
were disseminated. Seventeen respondents (including obstetricians, nurse practitioners, 
nurses, and diabetes educators) from the twelve pilot sites completed the toolkit survey at 
project completion. All respondents reported the provider toolkit was easy or somewhat easy 
to use and that they would continue to use at least one toolkit resource after project 
completion. Most sites (92 %) responded that resources within the provider toolkit were 
helpful or very helpful when treating patients. Recommendations for toolkit improvements 
included a need for additional instruction on when to use each tool or handout and when to 
provide the education to the clients (e.g. specific weeks of gestation). Respondents also 
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requested more emphasis on glucose testing postpartum, and the addition of guidance and 
resources to facilitate care coordination with PCPs postpartum.
All but one site reported that the patient toolkit resources were helpful in providing GDM-
related education to patients, and they would likely continue utilizing the patient resources 
after project completion. Sites responded that patient resources were easy to use, included 
valuable information on educational topics such as blood sugar monitoring, the impact of the 
diagnosis on mom and baby, and the importance of postpartum screening. However, 
information gained qualitatively during coaching calls pointed to a preference for and 
perceived usefulness of the GDM booklet over the general prenatal booklet. This 
information was reinforced by distribution; some sites used only the GDM booklet and 
returned their prenatal booklet.
Within the three sites that surveyed patients there were 83 respondents. Among them, 91 % 
reported that the GDM resources provided were either helpful or very helpful. Among 
patients with a diagnosis of GDM, 99 % indicated they would attend their postpartum visit, 
with 87 % responding that they would probably or definitely receive an oral glucose 
tolerance test (OGTT) test to determine their risk for T2DM.
For the quality improvement measures, nine to ten submissions were received monthly from 
the twelve participating sites over 11 months of reporting measures. These submissions 
represented prenatal data on more than 700 women, of whom 259 were diagnosed with 
GDM and had delivery recorded by the end of the project. Aggregate baseline and follow up 
findings for all measures are displayed in Table 1. Figure 4 displays an example of a trend 
chart for the measure of receipt of prenatal education on the risk of T2DM.
For all indicators of prenatal education, baseline measures were between 90 and 100 % of 
reviewed charts. Prenatal nutrition and weight gain education measures were already 
achieving approximately 100 % completion at baseline, which was maintained throughout 
the project period. Education on breastfeeding and exercise was slightly over 90 % at 
baseline and 100 % at follow-up. Improvement was seen for the three education measures 
that had lower baseline rates. Among reviewed charts at baseline and at month eleven, rates 
of prenatal education on T2DM risk were 67 and 100 %; family planning use (including 
spacing births) were 63 and 86 %; and smoking cessation were 40 and 90 %. For the 
measure of timeliness of prenatal GDM screening, 87 % of reviewed charts at baseline 
indicated screening prior to 28 weeks gestation and 95 % at project completion. The 
measure of a scheduled follow-up appointment following GDM diagnosis did not have 
baseline data available, as the follow-up appointment was a new process for many sites. At 
project end, 59 % of reviewed charts indicated a scheduled 30-minute follow-up 
appointment within 4-weeks of GDM diagnosis. Of women with a delivery recorded, 69 % 
had a completed postpartum visit. Of women who returned for their postpartum visit, 40 % 
had a documented T2DM screen.
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Recommendations for Future Practice
This paper describes an approach to improving care to prevent T2DM in a high-risk 
population through quality improvement methodology supported by provider and patient 
toolkits. The primary objectives of the initiative were to increase postpartum visits and 
postpartum T2DM screening in women following a GDM pregnancy. Secondary objectives 
were to increase patient education regarding T2DM and risk reduction methods. A 
complement of chart review data on quality improvement measures, records of site 
engagement, and surveys of practitoner and patient satisfaction supports the conclusion that 
this was a well-received initiative that improved delivery prenatal education and may have 
improved post-partum care receipt. Although numerous studies have identified major 
barriers to postpartum screening, we found few US studies (Ferrara 2012; Vesco 2012; 
Yarrington 2015) that have evaluated interventions to increase postpartum screening rates. 
Several were conducted within the same health maintenance organization, minimizing 
generalizability, and few used multimodal methods, a critical component for facilitating 
change in clinical practice. Strategies to date have relied either on the use of nurses for direct 
patient contact or on interventions utilizing the electronic medical record (Yarrington 2015).
Prior research has shown that resources to support clinical care for women with GDM both 
prenatally and postpartum are lacking and desired by practitioners (Oza-Frank 2014); that 
finding was supported by the Collaborative’s experience recruiting sites for participation in 
this initiative. We easily recruited sites as providers were eager to acquire tools to help them 
address this topic. This initiative appeared to meet at least some of that need as evidenced by 
high participation in the learning sessions, uptake of toolkits, and provider satisfaction with 
toolkits.
The Collaborative identified awareness of risks and benefits of optimal GDM management 
and risk reduction for T2DM as a key driver for improved postpartum care and 
improvements in education were a secondary objective of the initiative. Prenatal education 
on health behaviors and postpartum risks is believed to influence a woman’s behaviors and 
health care utilization postpartum (Hildebrand 2014; Hale 2014). Within participating sites 
measures of prenatal education on these topics appear to have improved. High rates of 
prenatal education on all topics were achieved at the end of the project period, based on 
chart review data reported on key measures. For some measures such as smoking cessation 
and family planning, the improvements appear to be large and may demonstrate potential for 
the use of quality improvement methods to address prenatal care.
The primary objective of this initiative was improvement of postpartum care. At project end, 
among women with GDM who had delivered 69 % had a record of a postpartum visit, 
slightly higher than rates of 20–60 % identified in recent studies (Yarrington 2015). 
However, rates remained suboptimal. Among the same women in this project, 40 % had a 
record of postpartum T2DM screening. While well within the wide range of published rates, 
it indicates a need for significant improvement beyond what was achieved in this pilot 
project.
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Reasons for missed postpartum care are numerous and the content of toolkits and learning 
sessions attempted to address many of them. Participating sites expressed particular 
frustration and desire for strategies when attempting to assure postpartum care for women 
who would receive that care from another provider. This is consistent with prior survey 
findings that showed both obstetricians/gynecologists (OB/GYNs) and PCPs identified care 
coordination as a barrier to improving postpartum screening and care among women with 
GDM (Ko 2013b; Rodgers 2014). Care coordination is (http://www.ahrq.gov/professionals/
prevention-chronic-care/improve/coordination/index.html) the deliberate organization of 
patient care activities and the sharing information among all participants in a patient’s care 
to achieve safer and more effective care. In the context of the postpartum T2DM screen, care 
coordination is challenged by the lack of a clear responsible provider for ordering and 
administering the test (OB/GYN or PCP). OB/GYNs are primarily responsible for 
diagnosing GDM and are often the sole healthcare provider for women during their 
reproductive years (Rayburn 2014). Although OB/GYNs are less likely than PCPs to 
conduct a postpartum screening (Stormo 2014), the transition to a PCP is inconsistent and 
variable. Furthermore, the results of the test must be given to the provider who will deliver 
appropriate follow-up care depending on the test results.
The findings presented are subject to limitations. First, while our primary objective was to 
improve postpartum care, we were not able to capture baseline information on postpartum 
care and missing postpartum data was common. Missing postpartum data likely biased 
downward the observed rates of postpartum visits and postpartum T2DM screen. Postpartum 
data could be missing when a woman either received postpartum care after the end of he 11 
months of data collection or when she received care from a provider other than the 
participating prenatal care site. In this project, five sites provided only prenatal care, while 
delivery and postpartum care were handled by other providers. Two of the sites that did not 
provide postpartum care attempted to obtain postpartum data from other providers, however 
their success was mixed. Second, when interpreting these findings it must be noted that the 
initiative was designed as a quality improvement initiative to produce measurable 
improvements within the participating sites, and not to produce generalizable findings.
Lessons learned from this pilot were used by the Collaborative to develop a second phase 
with three notable changes. First, the patient toolkit was updated to be inclusive of only one 
booklet focused on women diagnosed with GDM and incorporates some information from 
the general pregnancy booklet. Second, emphasis was added to care coordination within the 
provider toolkit resources (e.g., a letter template for communicating with the PCP), learning 
session content, and key measures (i.e., a measure of use of at least one care coordination 
strategy was developed). Care coordination strategies include ordering the OGTT screen 
during the delivery hospitalization, mailing a reminder postcard about the OGTT, and direct 
communication to the PCP regarding diagnosis and care recommendations. Third, efforts 
were made to improve the completeness of postpartum data, such as phone or fax follow up 
with the alternate provider. The Collaborative faced challenges receiving postpartum care 
data on women cared for by sites that don’t provide postpartum care. Rather than exclude 
theses sites new strategies to obtain data will be implemented. This model of care delivery is 
common for Ohio women with GDM (who may be referred to specialists for prenatal care 
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only and referred back to their general obstetric provider or PCP following delivery) and 
improving care within this delivery care model cannot be ignored.
This pilot quality improvement project demonstrated improvements in prenatal education 
and high acceptance of provider and patient toolkit resources. However, reported rates of 
postpartum visits and screening for T2DM suggest that additional strategies are necessary to 
support increased utilization of postpartum care. While much remains to be learned about 
how to optimize postpartum care for high risk women, this work has produced resources that 
support clinicians in providing care consistent with current guidelines and describe a 
promising approach to supporting change. The toolkit and learning session content can be 
freely accessed at http://www.ohiogdm.com. Future practice will build on the lessons 
learned, with an emphasis on care coordination, and aim to improve measurement of 
postpartum outcomes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Significance
Up to 70 % of women with gestational diabetes will develop Type 2 diabetes mellitus 
(T2DM). Postpartum and lifelong screening is recomended for timely identification of 
T2DM among women with a history of GDM. Low post-partum visit rates represent 
missed opportunities for screening for T2DM, providing prevention messages, and 
referral to early treatment. This project used quality improvement principles to improve 
clinic practices and rates of both postpartum visits and T2DM screening.
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Fig. 1. 
Key driver diagram for the quality improvement project of the ohio gestational diabetes 
postpartum care learning collaborative, 2014–2015
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Fig. 2. 
Prenatal care providers participating as quality improvement sites in the ohio gestational 
diabetes postpartum care learning collaborative (n = 15), 2014–2015
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Fig. 3. 
Project timeline
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Fig. 4. 
Compliance with prenatal education on the risk of type 2 diabetes mellitus (T2DM) among 
12 participating prenatal care sites during the project period
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